+1 (704) 266-3234

Global Adalimumab Biosimilar Market Professional Survey Report 2018

Published on: Apr 2018 | From USD $3500 | Published By: QY RESEARCH | Number Of Pages: 111

This report studies Adalimumab Biosimilar in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tablet
Oral Solution

By Application, the market can be split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Adalimumab Biosimilar Market Professional Survey Report 2018
1 Industry Overview of Adalimumab Biosimilar
1.1 Definition and Specifications of Adalimumab Biosimilar
1.1.1 Definition of Adalimumab Biosimilar
1.1.2 Specifications of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
1.2.1 Tablet
1.2.2 Oral Solution
1.3 Applications of Adalimumab Biosimilar
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.3 Manufacturing Process Analysis of Adalimumab Biosimilar
2.4 Industry Chain Structure of Adalimumab Biosimilar

3 Technical Data and Manufacturing Plants Analysis of Adalimumab Biosimilar
3.1 Capacity and Commercial Production Date of Global Adalimumab Biosimilar Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Adalimumab Biosimilar Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Adalimumab Biosimilar Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Adalimumab Biosimilar Major Manufacturers in 2017

4 Global Adalimumab Biosimilar Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Adalimumab Biosimilar Capacity and Growth Rate Analysis
4.2.2 2017 Adalimumab Biosimilar Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Adalimumab Biosimilar Sales and Growth Rate Analysis
4.3.2 2017 Adalimumab Biosimilar Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Adalimumab Biosimilar Sales Price
4.4.2 2017 Adalimumab Biosimilar Sales Price Analysis (Company Segment)

5 Adalimumab Biosimilar Regional Market Analysis
5.1 North America Adalimumab Biosimilar Market Analysis
5.1.1 North America Adalimumab Biosimilar Market Overview
5.1.2 North America 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.1.4 North America 2017 Adalimumab Biosimilar Market Share Analysis
5.2 China Adalimumab Biosimilar Market Analysis
5.2.1 China Adalimumab Biosimilar Market Overview
5.2.2 China 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.2.4 China 2017 Adalimumab Biosimilar Market Share Analysis
5.3 Europe Adalimumab Biosimilar Market Analysis
5.3.1 Europe Adalimumab Biosimilar Market Overview
5.3.2 Europe 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.3.4 Europe 2017 Adalimumab Biosimilar Market Share Analysis
5.4 Southeast Asia Adalimumab Biosimilar Market Analysis
5.4.1 Southeast Asia Adalimumab Biosimilar Market Overview
5.4.2 Southeast Asia 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.4.4 Southeast Asia 2017 Adalimumab Biosimilar Market Share Analysis
5.5 Japan Adalimumab Biosimilar Market Analysis
5.5.1 Japan Adalimumab Biosimilar Market Overview
5.5.2 Japan 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.5.4 Japan 2017 Adalimumab Biosimilar Market Share Analysis
5.6 India Adalimumab Biosimilar Market Analysis
5.6.1 India Adalimumab Biosimilar Market Overview
5.6.2 India 2013-2018E Adalimumab Biosimilar Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Adalimumab Biosimilar Sales Price Analysis
5.6.4 India 2017 Adalimumab Biosimilar Market Share Analysis

6 Global 2013-2018E Adalimumab Biosimilar Segment Market Analysis (by Type)
6.1 Global 2013-2018E Adalimumab Biosimilar Sales by Type
6.2 Different Types of Adalimumab Biosimilar Product Interview Price Analysis
6.3 Different Types of Adalimumab Biosimilar Product Driving Factors Analysis
6.3.1 Tablet of Adalimumab Biosimilar Growth Driving Factor Analysis
6.3.2 Oral Solution of Adalimumab Biosimilar Growth Driving Factor Analysis

7 Global 2013-2018E Adalimumab Biosimilar Segment Market Analysis (by Application)
7.1 Global 2013-2018E Adalimumab Biosimilar Consumption by Application
7.2 Different Application of Adalimumab Biosimilar Product Interview Price Analysis
7.3 Different Application of Adalimumab Biosimilar Product Driving Factors Analysis
7.3.1 Hospital Pharmacy of Adalimumab Biosimilar Growth Driving Factor Analysis
7.3.2 Retail Pharmacy of Adalimumab Biosimilar Growth Driving Factor Analysis
7.3.3 Online Pharmacy of Adalimumab Biosimilar Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Adalimumab Biosimilar
8.1 AET BioTech
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AET BioTech 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AET BioTech 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Amgen 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.3 Boehringer Ingelheim
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Boehringer Ingelheim 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Boehringer Ingelheim 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.4 Coherus Biosciences
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Coherus Biosciences 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Coherus Biosciences 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.5 Fujifilm Kyowa Kirin Biologics
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Fujifilm Kyowa Kirin Biologics 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Fujifilm Kyowa Kirin Biologics 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.6 LG Life Sciences/Mochida Pharmaceutical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 LG Life Sciences/Mochida Pharmaceutical 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 LG Life Sciences/Mochida Pharmaceutical 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.7 Momenta Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Momenta Pharmaceuticals 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Momenta Pharmaceuticals 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.8 Oncobiologics
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Oncobiologics 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Oncobiologics 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.9 Pfizer
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Pfizer 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Pfizer 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.10 Samsung Bioepsis
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Samsung Bioepsis 2017 Adalimumab Biosimilar Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Samsung Bioepsis 2017 Adalimumab Biosimilar Business Region Distribution Analysis
8.11 Sandoz
8.12 Zydus Cadila

9 Development Trend of Analysis of Adalimumab Biosimilar Market
9.1 Global Adalimumab Biosimilar Market Trend Analysis
9.1.1 Global 2018-2025 Adalimumab Biosimilar Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Adalimumab Biosimilar Sales Price Forecast
9.2 Adalimumab Biosimilar Regional Market Trend
9.2.1 North America 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.2.2 China 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.2.3 Europe 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.2.4 Southeast Asia 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.2.5 Japan 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.2.6 India 2018-2025 Adalimumab Biosimilar Consumption Forecast
9.3 Adalimumab Biosimilar Market Trend (Product Type)
9.4 Adalimumab Biosimilar Market Trend (Application)

10 Adalimumab Biosimilar Marketing Type Analysis
10.1 Adalimumab Biosimilar Regional Marketing Type Analysis
10.2 Adalimumab Biosimilar International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Adalimumab Biosimilar by Region
10.4 Adalimumab Biosimilar Supply Chain Analysis

11 Consumers Analysis of Adalimumab Biosimilar
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Adalimumab Biosimilar Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source


List of Tables and Figures
Figure Picture of Adalimumab Biosimilar
Table Product Specifications of Adalimumab Biosimilar
Table Classification of Adalimumab Biosimilar
Figure Global Production Market Share of Adalimumab Biosimilar by Type in 2017
Figure Tablet Picture
Table Major Manufacturers of Tablet
Figure Oral Solution Picture
Table Major Manufacturers of Oral Solution
Table Applications of Adalimumab Biosimilar
Figure Global Consumption Volume Market Share of Adalimumab Biosimilar by Application in 2017
Figure Hospital Pharmacy Examples
Table Major Consumers in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Major Consumers in Retail Pharmacy
Figure Online Pharmacy Examples
Table Major Consumers in Online Pharmacy
Figure Market Share of Adalimumab Biosimilar by Regions
Figure North America Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Figure China Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Figure Europe Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Figure Southeast Asia Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Figure Japan Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Figure India Adalimumab Biosimilar Market Size (Million USD) (2013-2025)
Table Adalimumab Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Adalimumab Biosimilar in 2017
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Industry Chain Structure of Adalimumab Biosimilar
Table Capacity and Commercial Production Date of Global Adalimumab Biosimilar Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Adalimumab Biosimilar Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Adalimumab Biosimilar Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Adalimumab Biosimilar Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Adalimumab Biosimilar 2013-2018E
Figure Global 2013-2018E Adalimumab Biosimilar Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Adalimumab Biosimilar Market Size (Value) and Growth Rate
Table 2013-2018E Global Adalimumab Biosimilar Capacity and Growth Rate
Table 2017 Global Adalimumab Biosimilar Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Adalimumab Biosimilar Sales (K Units) and Growth Rate
Table 2017 Global Adalimumab Biosimilar Sales (K Units) List (Company Segment)
Table 2013-2018E Global Adalimumab Biosimilar Sales Price (USD/Unit)
Table 2017 Global Adalimumab Biosimilar Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure North America 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure North America 2017 Adalimumab Biosimilar Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure China 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure China 2017 Adalimumab Biosimilar Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure Europe 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure Europe 2017 Adalimumab Biosimilar Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure Southeast Asia 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure Southeast Asia 2017 Adalimumab Biosimilar Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure Japan 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure Japan 2017 Adalimumab Biosimilar Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Adalimumab Biosimilar 2013-2018E
Figure India 2013-2018E Adalimumab Biosimilar Sales Price (USD/Unit)
Figure India 2017 Adalimumab Biosimilar Sales Market Share
Table Global 2013-2018E Adalimumab Biosimilar Sales (K Units) by Type
Table Different Types Adalimumab Biosimilar Product Interview Price
Table Global 2013-2018E Adalimumab Biosimilar Sales (K Units) by Application
Table Different Application Adalimumab Biosimilar Product Interview Price
Table AET BioTech Information List
Table Product A Overview
Table Product B Overview
Table 2017 AET BioTech Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 AET BioTech Adalimumab Biosimilar Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2017 Amgen Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Amgen Adalimumab Biosimilar Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2015 Boehringer Ingelheim Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Boehringer Ingelheim Adalimumab Biosimilar Business Region Distribution
Table Coherus Biosciences Information List
Table Product A Overview
Table Product B Overview
Table 2017 Coherus Biosciences Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Coherus Biosciences Adalimumab Biosimilar Business Region Distribution
Table Fujifilm Kyowa Kirin Biologics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Business Region Distribution
Table LG Life Sciences/Mochida Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2017 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Business Region Distribution
Table Momenta Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Momenta Pharmaceuticals Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Momenta Pharmaceuticals Adalimumab Biosimilar Business Region Distribution
Table Oncobiologics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Oncobiologics Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Oncobiologics Adalimumab Biosimilar Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2017 Pfizer Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Adalimumab Biosimilar Business Region Distribution
Table Samsung Bioepsis Information List
Table Product A Overview
Table Product B Overview
Table 2017 Samsung Bioepsis Adalimumab Biosimilar Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Samsung Bioepsis Adalimumab Biosimilar Business Region Distribution
Table Sandoz Information List
Table Zydus Cadila Information List
Figure Global 2018-2025 Adalimumab Biosimilar Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Adalimumab Biosimilar Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Adalimumab Biosimilar Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Adalimumab Biosimilar Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Adalimumab Biosimilar by Type 2018-2025
Table Global Consumption Volume (K Units) of Adalimumab Biosimilar by Application 2018-2025
Table Traders or Distributors with Contact Information of Adalimumab Biosimilar by Region

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3500
USD $4500
USD $7000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.